Policy – Page 4

Pharmaceutical tariffs, Section 232 investigation, Albert Bourla, national security, trade policy, manufacturing investments, Trump administration, supply chain concerns

Ex-FDA leader joins new initiative designed to fight ‘unfortunate reality’ of vaccine landscape

6 months ago talkbio0Tagged Ex-FDA, Initiative, Intact, M.D., Misinformation, Policy, Project, reality, Recommendation, threat, Vaccines

Vaccines, Project, Misinformation, Initiative, Policy, Intact, Ex-FDA, threat, Recommendation, M.D., reality

CMS would absorb 340B drug discount program under leaked HHS reorganization proposal

6 months ago talkbio0Tagged 340B, Centers for Medicare and Medicaid Services, Changing, CMS, drug discount program, HHS, Leaked, Policy, Programs - Publication Format, proposal - intent, reorganization, United States Health Resources and Services Administration

340B, Centers for Medicare and Medicaid Services, HHS, reorganization, Programs – Publication Format, proposal – intent, drug discount program, United States Health Resources and Services Administration, CMS, Policy, Leaked, Changing

New NIH grant rules override the Civil Rights Act of 1964, barring recipients from DEI activities

6 months ago talkbio0Tagged 1964, Changing, civil, Civil Rights Act, Condition, Diversity, federal, Israeli (population group), NIH, Policy, Protections, recipients, United States National Institutes of Health

United States National Institutes of Health, recipients, NIH, Policy, Diversity, Changing, Condition, civil, federal, civil, protections, recipients, Israeli (population group), Civil Rights Act, 1964

FDA moves to block biopharma employees from serving on advisory committees

6 months ago talkbio0Tagged Advisory Committees, Industry, Policy, United States Food and Drug Administration, Workers

United States Food and Drug Administration, Workers, Advisory Committees, Industry, Policy